Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


06.07.2020

2 Am J Respir Crit Care Med
1 Am J Surg
6 Ann Thorac Surg
3 Arch Bronconeumol
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Res
2 Carcinogenesis
1 Chest
3 Clin Lung Cancer
2 Eur J Cancer
2 Int J Cancer
1 J Cancer Res Clin Oncol
1 J Nucl Med
3 J Thorac Oncol
3 Lancet Oncol
7 Lung Cancer
5 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. LI J, Lu X, Liu F, Liang F, et al
    Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China.
    Am J Respir Crit Care Med. 2020 Jul 2. doi: 10.1164/rccm.202001-0002.
    PubMed         Abstract available

  2. QUAIFE SL, Ruparel M, Dickson JL, Beeken RJ, et al
    Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.
    Am J Respir Crit Care Med. 2020;201:965-975.
    PubMed         Abstract available


    Am J Surg

  3. LIMBACH KE, Pommier SJ, Dewey E, Leon E, et al
    Neuroendocrine metastases to the ovaries are significantly associated with small bowel neuroendocrine tumors and carcinomatosis.
    Am J Surg. 2020;219:795-799.
    PubMed         Abstract available


    Ann Thorac Surg

  4. HUANG L, Wu P, Li W, Chai Y, et al
    Combined Ectopic Variation of the Right Upper Pulmonary Vein and Bronchus.
    Ann Thorac Surg. 2020;109:e353-e355.
    PubMed         Abstract available

  5. UCHIBORI A, Okada S, Takeda-Miyata N, Tsunezuka H, et al
    Omental Flap for Bronchopleural Fistula After Pneumonectomy and Aorta Replacement.
    Ann Thorac Surg. 2020;109:e349-e351.
    PubMed         Abstract available

  6. SCHULBERG SP, Lim D, Hoda ST, Vaynblat M, et al
    Intrathoracic Myxoid Spindle Cell Lipoma: A Rare Presentation of a Myxoid Neoplasm.
    Ann Thorac Surg. 2020;109:e343-e345.
    PubMed         Abstract available

  7. NAKADA T, Noda Y, Kato D, Mori S, et al
    Simultaneous Two-Dimensional and Three-Dimensional Simulation of Thoracoscopic Sleeve Lobectomy: A Quick Understanding of Pitfalls.
    Ann Thorac Surg. 2020;109:e383-e385.
    PubMed         Abstract available

  8. SUDA K, Mitsudomi T, Shintani Y, Okami J, et al
    Clinical impacts of EGFR mutation status: analysis of 5,780 surgically resected lung cancer cases.
    Ann Thorac Surg. 2020 Jun 29. pii: S0003-4975(20)30982.
    PubMed         Abstract available

  9. MERRITT RE, Abdel-Rasoul M, Fitzgerald M, D'Souza DM, et al
    The Academic Facility Type is Associated with Improved Overall Survival for Early Stage Lung Cancer.
    Ann Thorac Surg. 2020 Jun 29. pii: S0003-4975(20)31015.
    PubMed         Abstract available


    Arch Bronconeumol

  10. FRAILE OLIVERO CA, Pardina Solano MA, Milla Collado L
    Intraoperatory Diagnosis of Partial Anomalous Pulmonary Venous Return During Pulmonary Resection Surgery in a Non-Small Cell Lung Cancer Patient.
    Arch Bronconeumol. 2020 Jun 25. pii: S0300-2896(20)30177.
    PubMed        

  11. MESA-GUZMAN M, Gonzalez J, Alcaide AB, Berto J, et al
    Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography.
    Arch Bronconeumol. 2020 Apr 23. pii: S0300-2896(20)30107.
    PubMed         Abstract available

  12. CAYUELA L, Lopez-Campos JL, Otero R, Rodriguez Portal JA, et al
    The Beginning of the Trend Change in Lung Cancer Mortality Trends in Spain, 1980-2018.
    Arch Bronconeumol. 2020 Jun 26. pii: S0300-2896(20)30182.
    PubMed         Abstract available


    Cancer

  13. IWAMA E, Sakai K, Hidaka N, Inoue K, et al
    Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
    Cancer. 2020;126:219-227.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  14. CHEN J, Huang X, Tao C, Wang L, et al
    Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo.
    Cancer Chemother Pharmacol. 2020 Jun 30. pii: 10.1007/s00280-020-04050.
    PubMed         Abstract available


    Cancer Res

  15. ZHOU ZW, Ambrogio C, Bera AK, Li Q, et al
    KRASQ61H preferentially signals through MAPK in a RAF dimer-dependent manner in non-small cell lung cancer.
    Cancer Res. 2020 Jun 30. pii: 0008-5472.CAN-20-0448.
    PubMed         Abstract available


    Carcinogenesis

  16. DENG S, Ramos-Castaneda M, Velasco WV, Clowers MJ, et al
    Interplay between Estrogen and Stat3/NF-kappaB Driven Immunomodulation in Lung Cancer.
    Carcinogenesis. 2020 Jun 30. pii: 5865334. doi: 10.1093.
    PubMed         Abstract available

  17. CHENG L, Liu Q, Wang M, Gu Y, et al
    Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small-cell lung carcinoma.
    Carcinogenesis. 2020 Jul 2. pii: 5866472. doi: 10.1093.
    PubMed         Abstract available


    Chest

  18. TANNER NT, Thomas NA, Ward R, Rojewski A, et al
    Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening.
    Chest. 2020 Jun 27. pii: S0012-3692(20)31822-5. doi: 10.1016/j.chest.2020.
    PubMed         Abstract available


    Clin Lung Cancer

  19. GOBBINI E, Toffart AC, Perol M, Assie JB, et al
    Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2020 May 8. pii: S1525-7304(20)30136.
    PubMed         Abstract available

  20. LUCIANI A, Marra A, Toschi L, Cortinovis D, et al
    Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged >/= 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
    Clin Lung Cancer. 2020 May 13. pii: S1525-7304(20)30144.
    PubMed         Abstract available

  21. MIURA S, Yamanaka T, Kato T, Ikeda S, et al
    Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834).
    Clin Lung Cancer. 2020 May 21. pii: S1525-7304(20)30151.
    PubMed         Abstract available


    Eur J Cancer

  22. CONFORTI F, Pala L, Pagan E, Bagnardi V, et al
    Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial.
    Eur J Cancer. 2020;125:94-103.
    PubMed         Abstract available

  23. BOULLE G, Velut Y, Mansuet-Lupo A, Gibault L, et al
    Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.
    Eur J Cancer. 2020;135:221-229.
    PubMed         Abstract available


    Int J Cancer

  24. BERGQVIST M, Christensen HN, Wiklund F, Bergstrom S, et al
    Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.
    Int J Cancer. 2020;146:2510-2517.
    PubMed         Abstract available

  25. DONG S, Ruiz-Calderon B, Rathinam R, Eastlack S, et al
    Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.
    Int J Cancer. 2020;146:2576-2587.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  26. LI WQ, Cui JW
    Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments.
    J Cancer Res Clin Oncol. 2020 Jun 28. pii: 10.1007/s00432-020-03296.
    PubMed         Abstract available


    J Nucl Med

  27. GIESEL F, Adeberg S, Syed M, Lindner T, et al
    FAPI-74 PET/CT Using Either (18)F-AlF or Cold-kit (68)Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.245084. doi: 10.2967/jnumed.120.245084.
    PubMed         Abstract available


    J Thorac Oncol

  28. PAZ-ARES L, Vicente D, Tafreshi A, Robinson A, et al
    A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer: Protocol-Specified Final Analysis of KEYNOTE-407.
    J Thorac Oncol. 2020 Jun 26. pii: S1556-0864(20)30500.
    PubMed         Abstract available

  29. SMELTZER MP, Osarogiagbon RU
    Out of the Darkness, Into Light: The Scientific Rigor of Lung Cancer Clinical Trials in the Age of Enlightenment.
    J Thorac Oncol. 2020;15:1110-1112.
    PubMed        

  30. KILADZE I, Mariamidze E, Jeremic B
    Lung Cancer in Georgia.
    J Thorac Oncol. 2020;15:1113-1118.
    PubMed        


    Lancet Oncol

  31. FAIVRE-FINN C
    Less is more in radiotherapy target volume planning: lessons from the PET-plan trial.
    Lancet Oncol. 2020 Mar 12. pii: S1470-2045(20)30108.
    PubMed        

  32. LASSEN U
    Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours.
    Lancet Oncol. 2020;21:193-194.
    PubMed        

  33. RAMELLA S, D'Angelillo RM
    Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer.
    Lancet Oncol. 2020;21:873-875.
    PubMed        


    Lung Cancer

  34. LEI Y, Feng H, Qiang H, Shang Z, et al
    Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
    Lung Cancer. 2020;146:244-251.
    PubMed         Abstract available

  35. CHEN C, Wang W, Yu Z, Tian S, et al
    Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy.
    Lung Cancer. 2020;146:290-296.
    PubMed         Abstract available

  36. SOMMER MS, Vibe-Petersen J, Staerkind MB, Langer SW, et al
    Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trial.
    Lung Cancer. 2020;146:285-289.
    PubMed         Abstract available

  37. GAGNE A, Orain M, Ionescu D, Tsao MS, et al
    Comprehensive assessment of PD-L1 immunohistochemistry on paired tissue and cytology specimens from non-small cell lung cancer.
    Lung Cancer. 2020;146:276-284.
    PubMed         Abstract available

  38. NICOSIA L, Di Muzio J, Agolli L, Alongi F, et al
    What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer?
    Lung Cancer. 2020;146:263-275.
    PubMed         Abstract available

  39. HUANG M, Insinga RP, Burke T, Zhang Y, et al
    In response to She et al., "Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater".
    Lung Cancer. 2020 Jun 17. pii: S0169-5002(20)30489.
    PubMed        

  40. LU S, Chen G, Sun Y, Sun S, et al
    A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study.
    Lung Cancer. 2020;146:252-262.
    PubMed         Abstract available


    PLoS One

  41. KEMBOU NZALE S, Weeks WB, Ouafik L, Rouquette I, et al
    Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study.
    PLoS One. 2020;15:e0234387.
    PubMed         Abstract available

  42. CHEN R, Lin J
    Correction: Identification of feature risk pathways of smoking-induced lung cancer based on SVM.
    PLoS One. 2020;15:e0235854.
    PubMed         Abstract available

  43. STEINHAUSER MOTTA JP, Steffen RE, Samary Lobato C, Souza Mendonca V, et al
    Endobronchial ultrasound-guided transbronchial needle aspiration versus mediastinoscopy for mediastinal staging of lung cancer: A systematic review of economic evaluation studies.
    PLoS One. 2020;15:e0235479.
    PubMed         Abstract available

  44. SONG MJ, Kim DJ, Paik HC, Cho S, et al
    Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I-III non-small cell lung cancer.
    PLoS One. 2020;15:e0235126.
    PubMed         Abstract available

  45. LOPEZ-GARCIA G, Jerez JM, Franco L, Veredas FJ, et al
    Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data.
    PLoS One. 2020;15:e0230536.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  46. JIANG H, Cao HJ, Ma N, Bao WD, et al
    Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
    Proc Natl Acad Sci U S A. 2020;117:4770-4780.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: